What does Dr. Heide De Haene, klinisch bioloog do?

Dr. Heide De Haene, klinisch bioloog is a healthcare practice in Gent. Private Limited, started on 1 September 2005, 1 establishment.

What is the address of Dr. Heide De Haene, klinisch bioloog?

The registered office of Dr. Heide De Haene, klinisch bioloog is located at Beekstraatkouter 69, 9031 Gent.

Is Dr. Heide De Haene, klinisch bioloog still active?

Yes. According to the CBE (2 November 2026) Dr. Heide De Haene, klinisch bioloog is active, legal situation “Normale toestand”, started on 1 September 2005.

Is Dr. Heide De Haene, klinisch bioloog registered on Peppol?

Yes, Dr. Heide De Haene, klinisch bioloog is registered on the Peppol network with ID 0208:0875808644.

What is the enterprise number of Dr. Heide De Haene, klinisch bioloog?

The enterprise number of Dr. Heide De Haene, klinisch bioloog is BE0875808644.

When was Dr. Heide De Haene, klinisch bioloog founded?

Dr. Heide De Haene, klinisch bioloog was founded on 1 September 2005.

Who are the directors of Dr. Heide De Haene, klinisch bioloog?

According to the 2025 annual accounts, the directors of Dr. Heide De Haene, klinisch bioloog are: Heide De Haene.

Is Dr. Heide De Haene, klinisch bioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 September 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 events from the Belgian Official Gazette processed.

How much profit did Dr. Heide De Haene, klinisch bioloog make in 2025?

Dr. Heide De Haene, klinisch bioloog posted a profit after taxes of € 154,000 in financial year 2025.

What is the revenue of Dr. Heide De Haene, klinisch bioloog?

As a small company, Dr. Heide De Haene, klinisch bioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 295,173.

Dr. Heide De Haene, klinisch bioloog (Private Limited)

Dossier Dr. Heide De Haene, klinisch bioloog, printed on 3 November 2026 from databakkes.be/en/0875808644/dr-heide-de-haene-klinisch-bioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Heide De Haene, klinisch bioloog from Gent, company number BE0875808644, closed financial year 2025 with a result of € 154,000 after tax. For that financial year Dr. Heide De Haene, klinisch bioloog recorded a gross margin of € 295,173 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 135,510 to € 154,000. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.

What it is worth Growing

€ 1.1 million

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 154,000

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 251,883

▲ 128% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 937,861.

People and assets in 2025

Vehicles and equipment

€ 620

▼ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 637,681

▼ 41% vs 2024

€ 56,561 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 1,704

▼ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,698

▲ 57% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 176,124 Gross margin 2022: € 176,124 First fiscal year in the series	€ 283,600 Gross margin 2023: € 283,600 ▲ 61% vs 2022 (€ 176,124) Favourable step	€ 276,525 Gross margin 2024: € 276,525 ▼ 2% vs 2023 (€ 283,600) Unfavourable step	€ 295,173 Gross margin 2025: € 295,173 ▲ 7% vs 2024 (€ 276,525) Favourable step	▲ 7%
Profit after taxes	€ 67,557 Profit after taxes 2022: € 67,557 First fiscal year in the series	€ 143,953 Profit after taxes 2023: € 143,953 ▲ 113% vs 2022 (€ 67,557) Favourable step	€ 135,510 Profit after taxes 2024: € 135,510 ▼ 6% vs 2023 (€ 143,953) Unfavourable step	€ 154,000 Profit after taxes 2025: € 154,000 ▲ 14% vs 2024 (€ 135,510) Favourable step	▲ 14%
Equity	€ 729,099 Equity 2022: € 729,099 First fiscal year in the series	€ 783,051 Equity 2023: € 783,051 ▲ 7% vs 2022 (€ 729,099) Favourable step	€ 918,561 Equity 2024: € 918,561 ▲ 17% vs 2023 (€ 783,051) Favourable step	€ 1,072,561 Equity 2025: € 1,072,561 ▲ 17% vs 2024 (€ 918,561) Favourable step	▲ 17%
Total debts	€ 1,264,862 Total debts 2022: € 1,264,862 First fiscal year in the series	€ 1,290,006 Total debts 2023: € 1,290,006 ▲ 2% vs 2022 (€ 1,264,862) Unfavourable step	€ 1,209,955 Total debts 2024: € 1,209,955 ▼ 6% vs 2023 (€ 1,290,006) Favourable step	€ 772,881 Total debts 2025: € 772,881 ▼ 36% vs 2024 (€ 1,209,955) Favourable step	▼ 36%
Cash	€ 29,268 Cash 2022: € 29,268 First fiscal year in the series	€ 25,440 Cash 2023: € 25,440 ▼ 13% vs 2022 (€ 29,268) Unfavourable step	€ 110,508 Cash 2024: € 110,508 ▲ € 85,068 vs 2023 (€ 25,440) Favourable step	€ 251,883 Cash 2025: € 251,883 ▲ 128% vs 2024 (€ 110,508) Favourable step	▲ 128%
Land & buildings	€ 1,736,894 Land & buildings 2022: € 1,736,894 First fiscal year in the series	€ 1,780,439 Land & buildings 2023: € 1,780,439 ▲ 3% vs 2022 (€ 1,736,894) Unchanged	€ 1,738,169 Land & buildings 2024: € 1,738,169 ▼ 2% vs 2023 (€ 1,780,439) Unchanged	€ 1,274,289 Land & buildings 2025: € 1,274,289 ▼ 27% vs 2024 (€ 1,738,169) Unchanged	▼ 27%
Retained profit	€ 594,399 Retained profit 2022: € 594,399 First fiscal year in the series	€ 648,351 Retained profit 2023: € 648,351 ▲ 9% vs 2022 (€ 594,399) Favourable step	€ 783,861 Retained profit 2024: € 783,861 ▲ 21% vs 2023 (€ 648,351) Favourable step	€ 937,861 Retained profit 2025: € 937,861 ▲ 20% vs 2024 (€ 783,861) Favourable step	▲ 20%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 90,000 Dividend 2023: € 90,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 90,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 1,229,426 Bank debt 2022: € 1,229,426 First fiscal year in the series	€ 1,150,046 Bank debt 2023: € 1,150,046 ▼ 6% vs 2022 (€ 1,229,426) Favourable step	€ 1,083,884 Bank debt 2024: € 1,083,884 ▼ 6% vs 2023 (€ 1,150,046) Favourable step	€ 637,681 Bank debt 2025: € 637,681 ▼ 41% vs 2024 (€ 1,083,884) Favourable step	▼ 41%
Balance sheet total	€ 1,993,960 Balance sheet total 2022: € 1,993,960 First fiscal year in the series	€ 2,073,057 Balance sheet total 2023: € 2,073,057 ▲ 4% vs 2022 (€ 1,993,960) Unchanged	€ 2,128,516 Balance sheet total 2024: € 2,128,516 ▲ 3% vs 2023 (€ 2,073,057) Unchanged	€ 1,845,442 Balance sheet total 2025: € 1,845,442 ▼ 13% vs 2024 (€ 2,128,516) Unchanged	▼ 13%

Key figures of Dr. Heide De Haene, klinisch bioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Heide De Haene, klinisch bioloog?

What happened at Dr. Heide De Haene, klinisch bioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 10, 2026 New annual accounts for financial year 2025: profit of € 154,000 (▲ 14% vs 2024). Source: NBB ↗
Mar 6, 2014 Capital increase of € 116,100, published in the Gazette. Source: Staatsblad ↗
Sep 8, 2005 Incorporation, published in the Gazette. Source: Staatsblad ↗
Sep 1, 2005 New establishment in Gent. KBO

In short

From € 67,557 profit in 2022 to € 154,000 profit in 2025.

Paid € 213,589 in corporate taxes since 2022.

Best year ever: 2025, with € 154,000 profit.

Paid out € 90,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Heide De Haene

Dr. Heide De Haene, klinisch bioloog

Behind Dr. Heide De Haene, klinisch bioloog is Heide De Haene.

Directors

According to the 2025 annual accounts

Heide De Haene

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Beekstraatkouter 69

9031 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Capital increase

6 March 2014 Source: Deed ↗

De Haene Heide(enige vennoot) 60.3%

Incorporation

8 September 2005 Source: Deed ↗

DE HAENE Heide Leen Omer(oprichter) 100%

Details

Company number

0875.808.644

VAT number

BE 0875.808.644

Registered office

Beekstraatkouter 69, 9031 Gent

Names & denominations

Dr. Heide De Haene, klinisch bioloog

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 September 2005

Peppol

Active · Active since 10 Nov 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Heide De Haene, klinisch bioloog

Financials

What happened to Dr. Heide De Haene, klinisch bioloog?

Management

Directors

Establishments

Establishment units

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions